Cabozantinib improves progression-free survival in metastatic renal cell carcinoma
Cancer October 12, 2016, 0 Comment 9Cabozantinib significantly improves progression-free survival and response rate in patients with metastatic renal cell carcinoma compared to sunitinib, according to research presented at the ESMO…
Author
Leave a comment